D M F M van der Heijde

Summary

Affiliation: University Hospital Maastricht
Country: The Netherlands

Publications

  1. ncbi Is avoidant coping independent of disease status and stable over time in patients with ankylosing spondylitis?
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands
    Ann Rheum Dis 63:1264-8. 2004
  2. ncbi Magnetic resonance imaging changes of sacroiliac joints in patients with recent-onset inflammatory back pain: inter-reader reliability and prevalence of abnormalities
    Liesbeth Heuft-Dorenbosch
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Arthritis Res Ther 8:R11. 2006
  3. ncbi [Aspects of the radiological evaluation of rheumatoid arthritis]
    D van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Med Interne (Paris) 152:518-21. 2001
  4. ncbi How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion
    Desiree van der Heijde
    Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands
    Arthritis Rheum 47:215-8. 2002
  5. ncbi Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study
    Desiree van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital, Maastricht, The Netherlands
    Arthritis Rheum 52:1205-15. 2005
  6. ncbi Psoriatic arthritis imaging: a review of scoring methods
    D van der Heijde
    Department of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 64:ii61-4. 2005
  7. ncbi Structural damage in rheumatoid arthritis as visualized through radiographs
    Desiree van der Heijde
    University Hospital Maastricht, Maastricht, The Netherlands
    Arthritis Res 4:S29-33. 2002
  8. ncbi Treatment trials in ankylosing spondylitis: current and future considerations
    D van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 61:iii24-32. 2002
  9. ncbi ASessment in Ankylosing Spondylitis (ASAS) international working group: a model for psoriatic arthritis and psoriasis?
    D van der Heijde
    Divison of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 64:ii108-9. 2005
  10. ncbi New directions in classification and outcome assessment in ankylosing spondylitis
    Desiree van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, Caphri Research Institute, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Curr Rheumatol Rep 6:98-101. 2004

Detail Information

Publications88

  1. ncbi Is avoidant coping independent of disease status and stable over time in patients with ankylosing spondylitis?
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands
    Ann Rheum Dis 63:1264-8. 2004
    ..To determine whether avoidant coping in ankylosing spondylitis (AS) is independent of disease status and whether it is stable over time...
  2. ncbi Magnetic resonance imaging changes of sacroiliac joints in patients with recent-onset inflammatory back pain: inter-reader reliability and prevalence of abnormalities
    Liesbeth Heuft-Dorenbosch
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Arthritis Res Ther 8:R11. 2006
    ..About one-third of patients with recent-onset inflammatory back pain show inflammation, and about one-sixth show structural changes in at least one SI joint...
  3. ncbi [Aspects of the radiological evaluation of rheumatoid arthritis]
    D van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Med Interne (Paris) 152:518-21. 2001
    ..For use in clinical practice the SENS method is more feasible. Several drugs are capable of retarding radiographic progression. However, it is difficult to compare results across trials and these difficulties are elaborated...
  4. ncbi How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion
    Desiree van der Heijde
    Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands
    Arthritis Rheum 47:215-8. 2002
  5. ncbi Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study
    Desiree van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital, Maastricht, The Netherlands
    Arthritis Rheum 52:1205-15. 2005
    ..To assess the efficacy, safety, and tolerability of etoricoxib, a cyclooxygenase 2 (COX-2) selective inhibitor, administered continuously over 52 weeks for the treatment of ankylosing spondylitis (AS)...
  6. ncbi Psoriatic arthritis imaging: a review of scoring methods
    D van der Heijde
    Department of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 64:ii61-4. 2005
    ..This article reviews the available scoring methods. A full description of the methods is given as well as information on various aspects of validity...
  7. ncbi Structural damage in rheumatoid arthritis as visualized through radiographs
    Desiree van der Heijde
    University Hospital Maastricht, Maastricht, The Netherlands
    Arthritis Res 4:S29-33. 2002
    ..A guide in the interpretation and clinical relevance of radiographic results is presented, with the Anti-TNF Trial in Rheumatoid Arthritis with Concomitant Therapy used as an example...
  8. ncbi Treatment trials in ankylosing spondylitis: current and future considerations
    D van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 61:iii24-32. 2002
    ..The FDA has defined the claims that sponsors can receive for RA products and the clinical trial data that would be expected to be submitted to support such claims...
  9. ncbi ASessment in Ankylosing Spondylitis (ASAS) international working group: a model for psoriatic arthritis and psoriasis?
    D van der Heijde
    Divison of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 64:ii108-9. 2005
  10. ncbi New directions in classification and outcome assessment in ankylosing spondylitis
    Desiree van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, Caphri Research Institute, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Curr Rheumatol Rep 6:98-101. 2004
    ..Responders as defined by the Assessment in Ankylosing Spondylitis response criteria also are considered by the experts as responders...
  11. ncbi ASsessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis
    Desiree van der Heijde
    University Hospital Maastricht, and the Care and Public Health Research Institute of the University Maastricht, Maastricht, The Netherlands
    Arthritis Rheum 52:386-94. 2005
  12. ncbi OMERACT workshop: repair of structural damage in rheumatoid arthritis
    Desiree van der Heijde
    University Hospital Maastricht, Maastricht, The Netherlands
    J Rheumatol 30:1108-9. 2003
    ....
  13. ncbi Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study
    Desiree van der Heijde
    Rheumatology Department, University Hospital, Maastricht, The Netherlands
    Arthritis Rheum 52:49-60. 2005
    ..To evaluate different methods of presentation and analysis of radiographic data in a rheumatoid arthritis (RA) randomized controlled trial...
  14. ncbi Overview of radiologic efficacy of new treatments
    D M F M van der Heijde
    Division of Rheumatology, Department of Internal Medicine, University Hospital Maastricht, P O Box 5800, 6202 AZ Maastricht, The Netherlands
    Rheum Dis Clin North Am 30:285-93, vi. 2004
    ..The relative efficacy of these new treatments is unknown. Head-to-head comparisons have not been performed and comparing treatment arms across trials has several pitfalls. These possible pitfalls are discussed...
  15. ncbi Long term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 years
    D van der Heijde
    Division of Internal Medicine, Department of Rheumatology, University Hospital Maastricht, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 63:737-9. 2004
    ..To assess the effect of long term (>2 years) leflunomide treatment on radiographic progression in patients with RA...
  16. ncbi Impact of imaging in established rheumatoid arthritis
    Desiree van der Heijde
    University Hospital Maastricht, P O Box 5800, 6202 AZ, Maastricht, The Netherlands
    Best Pract Res Clin Rheumatol 17:783-90. 2003
    ..The significance and clinical implication of a certain magnitude of change in the modified Sharp score is discussed...
  17. ncbi Imaging: do erosions heal?
    D van der Heijde
    University Hospital Maastricht, Department of Internal Medicine Rheumatology, and Care and Public Health Research Institute, University Maastricht, Maastricht, The Netherlands
    Ann Rheum Dis 62:ii10-2. 2003
    ..Application of this technique may give us better information on the effects of new drugs on the induction of repair...
  18. ncbi Radiographic progression in rheumatoid arthritis: does it reflect outcome? Does it reflect treatment?
    D van der Heijde
    University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 60:iii47-50. 2001
    ..Disease activity is always strongly correlated with functional disability throughout the disease course. There is an increasing relation between disability and structural damage with increasing disease duration...
  19. ncbi Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results
    D van der Heijde
    Rheumatology Department, University Hospital, Maastricht, PO Box 5800, 6202 AZ Maastricht, P Debyelaan 25, 6229 HX Maastricht, The Netherlands
    Ann Rheum Dis 64:1582-7. 2005
    ..To assess methods to calculate achieving and sustaining remission in a double blind randomised trial in patients with RA who received etanercept, methotrexate, or an etanercept/methotrexate combination...
  20. ncbi Imaging in spondylitis
    Desiree van der Heijde
    University Hospital Maastricht and CAPHRI Research Institute, Maastricht, The Netherlands
    Curr Opin Rheumatol 17:413-7. 2005
    ..The purpose of this review is to describe and evaluate recent findings with respect to imaging in ankylosing spondylitis. The review includes articles from the literature that were published in 2004...
  21. ncbi Methodological issues in radiographic scoring methods in rheumatoid arthritis
    D van der Heijde
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    J Rheumatol 26:726-30. 1999
    ....
  22. ncbi How to read radiographs according to the Sharp/van der Heijde method
    D van der Heijde
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    J Rheumatol 26:743-5. 1999
    ..This article is a short overview of the development of the Sharp/van der Heijde method for scoring radiographs of hands and feet in rheumatoid arthritis, in addition to a detailed description on how to use the scoring method...
  23. ncbi Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis
    D van der Heijde
    Department of Internal Medicine, University of Maastricht, The Netherlands
    J Rheumatol 26:951-4. 1999
    ..It is recommended to use these instruments in all research projects in AS...
  24. ncbi Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial
    Desiree van der Heijde
    University Hospital Maastricht, Maastricht, The Netherlands
    Arthritis Rheum 55:569-74. 2006
    ....
  25. ncbi Plain radiographs as an outcome measure in ankylosing spondylitis
    D van der Heijde
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    J Rheumatol 26:985-7. 1999
    ..Methodological issues that can be addressed concerning radiographic scoring methods are discussed in detail. A short introduction to the available scoring methods is presented...
  26. ncbi Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial
    Desiree van der Heijde
    Department of Rheumatology, University Hospital, Maastricht, The Netherlands
    Arthritis Rheum 54:1063-74. 2006
    ....
  27. ncbi Alternative methods for analysis of radiographic damage in a randomized, double blind, parallel group clinical trial comparing hydroxychloroquine and sulfasalazine
    D M van der Heijde
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    J Rheumatol 27:535-8; discussion 538-9. 2000
    ..Regardless of which method is used, there is a statistically significant reduction in radiographic progression in the SASP group compared to the HCQ group...
  28. ncbi Selection of a method for scoring radiographs for ankylosing spondylitis clinical trials, by the Assessment in Ankylosing Spondylitis Working Group and OMERACT
    Desiree van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, University Maastricht, 6202 AZ Maastricht, The Netherlands
    J Rheumatol 32:2048-9. 2005
    ..Finally, both the ASAS Working Group and OMERACT participants voted for the modified Stoke AS Spinal Score (mSASSS) as the preferred scoring method for use in clinical trials in AS...
  29. ncbi Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)
    Desiree van der Heijde
    University Hospital Maastricht, Maastricht, The Netherlands
    Arthritis Rheum 52:582-91. 2005
    ..The objective of this multicenter, randomized, placebo-controlled study was to evaluate the efficacy and safety of infliximab in patients with AS...
  30. ncbi Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7
    Desiree M F M Van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, University Maastricht, 6202 AZ Maastricht, The Netherlands
    J Rheumatol 32:2042-7. 2005
    ..Research on assessing structural damage was considered less important. The specific process and results of this initiative are discussed...
  31. ncbi Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force
    D van der Heijde
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    J Rheumatol 28:914-7. 2001
    ....
  32. ncbi Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial
    D van der Heijde
    Rheumatology, University Hospital Maastricht, Maastricht, The Netherlands
    Ann Rheum Dis 65:328-34. 2006
    ..To compare patient reported measures of function, health related quality of life (QoL), and satisfaction with medication among patients with rheumatoid arthritis (RA) treated with methotrexate (MTX), etanercept, or both for up to 1 year...
  33. ncbi How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?
    Desiree van der Heijde
    University Hospital Maastricht and CAPHRI Research Institute, Maastricht, The Netherlands
    Arthritis Rheum 52:1979-85. 2005
  34. ncbi Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis
    D van der Heijde
    Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
    Arthritis Rheum 56:3928-39. 2007
    ..The results after 1 and 2 years of the study have been previously reported. Here we provide the 3-year clinical and radiographic outcomes and safety of etanercept, methotrexate, and the combination in patients with RA...
  35. ncbi Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis
    N B Klarenbeek
    Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
    Ann Rheum Dis 70:1815-21. 2011
    ....
  36. ncbi The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction
    P P Geusens
    University Hospital, Maastricht, The Netherlands
    Arthritis Rheum 54:1772-7. 2006
    ....
  37. ncbi Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives
    A Spoorenberg
    Department of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Rheumatology (Oxford) 44:789-95. 2005
    ..CONCLUSION: AS patients rate disease activity on the basis of complaints while physicians rate disease activity on the basis of instruments related to disease severity and inflammation...
  38. ncbi Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial
    D van der Heijde
    Department of Rheumatology, Leiden University Medical Centre, PO Box 9600, 2300 CC Leiden, The Netherlands
    Ann Rheum Dis 67:1267-70. 2008
    ..Aim: To investigate the longitudinal relationship between physical function and both the level of radiographic damage and the radiographic progression rate in patients with early or advanced active rheumatoid arthritis...
  39. ncbi Reliability and sensitivity to change of the Simple Erosion Narrowing Score compared with the Sharp-van der Heijde method for scoring radiographs in rheumatoid arthritis
    E M Dias
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, Maastricht, The Netherlands
    Ann Rheum Dis 67:375-9. 2008
    ..To compare the performance of a simplified scoring method for structural damage on radiographs of patients with rheumatoid arthritis (the Simple Erosion Narrowing Score or SENS) with the Sharp-van der Heijde Score (SHS) as reference...
  40. ncbi Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial
    D van der Heijde
    Department of Rheumatology, Leiden University Medical Center, The Netherlands
    Ann Rheum Dis 68:922-9. 2009
    ....
  41. ncbi Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy
    D van der Heijde
    Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
    Ann Rheum Dis 68:1113-8. 2009
    ..To determine the effect of changing from etanercept or methotrexate monotherapy to etanercept plus methotrexate combination therapy on radiographic progression in rheumatoid arthritis (RA) patients...
  42. ncbi Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis
    R B M Landewé
    Department of Internal Medicine Rheumatology, University Hospital Maastricht, Netherlands
    Ann Rheum Dis 65:40-4. 2006
    ..Markers of collagen type I (CTX-1) and type II (CTX-II) degradation, reflecting bone and cartilage breakdown, appear to predict long term radiographic progression in chronic persistent arthritis...
  43. ncbi Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis
    D van der Heijde
    University Hospital Maastricht, Maastricht, The Netherlands
    Ann Rheum Dis 65:1572-7. 2006
    ..CONCLUSIONS: Patients with ankylosing spondylitis can expect a comparable significant improvement in clinical outcomes with similar safety when treated with etanercept 50 mg once weekly or with 25 mg twice weekly...
  44. ncbi A systematic comparison of rheumatoid arthritis and ankylosing spondylitis: structural outcomes
    R Landewe
    Maastricht University Medical Center, Maastricht, The Netherlands
    Clin Exp Rheumatol 27:S102-7. 2009
    ..In this article, similarities and dissimilarities with respect to structural damage in RA and AS are discussed and set against a background...
  45. ncbi Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis
    A van Tubergen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, Maastricht, The Netherlands
    Ann Rheum Dis 62:140-5. 2003
    ..In AS, a short term change on the WHODAS II is associated with a change in physical function. At the group level, disease activity and physical functioning may predict disability after five years...
  46. ncbi Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab
    N B Klarenbeek
    Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
    Ann Rheum Dis 69:2107-13. 2010
    ..To assess the relationship between joint tenderness, swelling and joint damage progression in individual joints and to evaluate the influence of treatment on these relationships...
  47. ncbi Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?
    A Wanders
    University Hospital Maastricht, Department of Internal Medicine, Division of Rheumatology, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 64:988-94. 2005
    ....
  48. ncbi Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic
    L Heuft Dorenbosch
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202AZ Maastricht, The Netherlands
    Ann Rheum Dis 66:92-8. 2007
    ....
  49. ncbi Proposal of a linear definition of the Bath Ankylosing Spondylitis Metrology Index (BASMI) and comparison with the 2-step and 10-step definitions
    D van der Heijde
    Department of Rheumatology, Leiden University Medical Center, Leiden, PO Box 9600, 2300 RC Leiden, The Netherlands
    Ann Rheum Dis 67:489-93. 2008
    ..For metric purposes, we recently defined a BASMI version with linear score definitions. Aim: to evaluate agreement between three BASMI definitions and to test sensitivity to change...
  50. ncbi Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group
    D van der Heijde
    Department of Internal Medicine, University of Maastricht, The Netherlands
    J Rheumatol 24:2225-9. 1997
    ..Three preliminary core sets for AS have been defined. Further research will be performed to select specific measures for all domains...
  51. ncbi Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow up
    K Bruynesteyn
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 63:1413-8. 2004
    ..CONCLUSIONS: Changes in joint damage due to RA can be detected reliably already within 3 months. This finding can be used to plan short term, randomised controlled trials with radiographic progression as primary outcome...
  52. ncbi ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis
    D van der Heijde
    Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
    Ann Rheum Dis 68:1811-8. 2009
    ....
  53. ncbi Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
    R Knevel
    Department of Rheumatology, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, Albinusdreef 2, The Netherlands
    Ann Rheum Dis 69:987-94. 2010
    ..To perform a systematic literature review of effective strategies for the treatment of rheumatoid arthritis (RA)...
  54. ncbi Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy
    E de Klerk
    Department of Rheumatology, University Hospital Maastricht, The Netherlands
    J Rheumatol 26:2635-41. 1999
    ..To develop a rheumatology oriented questionnaire that measures compliance to drug regimen and identifies factors that contribute to suboptimal compliance in patients with rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), and gout...
  55. ncbi Radiological scoring methods in ankylosing spondylitis: reliability and sensitivity to change over one year
    A Spoorenberg
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    J Rheumatol 26:997-1002. 1999
    ..There was moderate to good agreement on no change between the observers. No method showed change over a period of one year in a considerable number of patients...
  56. ncbi Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis
    A Spoorenberg
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    J Rheumatol 26:980-4. 1999
    ..The positive predictive values of CRP and ESR in our setting were low (0.15-0.69). We conclude that neither CRP nor ESR is superior to assess disease activity...
  57. ncbi Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine
    R Landewe
    Department of Internal Medicine, Maastricht University Medical Centre, The Netherlands
    Ann Rheum Dis 68:863-7. 2009
    ..Univariate correlations were calculated on baseline values using the Spearman rank correlation. Multivariate associations were investigated by generalised estimating equations (GEE) on baseline and 2-year data...
  58. ncbi A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis
    A Spoorenberg
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    J Rheumatol 26:961-5. 1999
    ..Average misclassification between BASFI, DFI and DA was 23 and 27%, respectively. Both BASFI and DFI correlate equally well with disease activity and damage...
  59. ncbi Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E
    K Visser
    Leiden University Medical Center, Department of Rheumatology, Leiden, The Netherlands
    Ann Rheum Dis 68:1086-93. 2009
    ..To develop evidence-based recommendations for the use of methotrexate in daily clinical practice in rheumatic disorders...
  60. ncbi Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients
    A Boonen
    Department of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 60:353-8. 2001
    ..To evaluate employment status, work disability, and work days lost in patients with ankylosing spondylitis (AS)...
  61. ncbi Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis
    D Vosse
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Rheumatology (Oxford) 47:1219-22. 2008
    ....
  62. ncbi Comparing morphometric X-ray absorptiometry and radiography in defining vertebral wedge fractures in patients with ankylosing spondylitis
    D Vosse
    Department of Internal Medicine, Division of Rheumatology University Hospital, PO Box 58006202 AZ Maastricht, The Netherlands
    Rheumatology (Oxford) 46:1667-71. 2007
    ....
  63. ncbi Presentation and analysis of radiographic data in clinical trials and observational studies
    R Landewe
    University Hospital Maastricht, Department of Internal Medicine Rheumatology, PO Box 5800, 6202AZ Maastricht, The Netherlands
    Ann Rheum Dis 64:iv48-51. 2005
    ....
  64. ncbi Willingness of patients with ankylosing spondylitis to pay for inpatient treatment is influenced by the treatment environment and expectations of improvement
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 64:1650-2. 2005
    ..To assess the willingness to pay (WTP) for treatment in a spa resort of patients with ankylosing spondylitis (AS) and to assess if the experience of a spa influences the WTP...
  65. ncbi Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands
    Ann Rheum Dis 64:396-402. 2005
    ..To compare the cost of illness of three musculoskeletal conditions in relation to general wellbeing...
  66. ncbi Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 62:732-40. 2003
    ..To assess direct costs associated with ankylosing spondylitis (AS). To determine which variables, including country, predict costs...
  67. ncbi Assessment of enthesitis in ankylosing spondylitis
    L Heuft-Dorenbosch
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, Maastricht, The Netherlands
    Ann Rheum Dis 62:127-32. 2003
    ....
  68. ncbi Costs of ankylosing spondylitis in three European countries: the patient's perspective
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 62:741-7. 2003
    ..To assess a patient's out of pocket costs, income loss, time consumption, and quality of life (QoL) due to ankylosing spondylitis (AS) in three European countries and to assess variables predicting these outcomes...
  69. ncbi Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 61:429-37. 2002
    ..To compare work disability, sick leave, and productivity costs due to ankylosing spondylitis (AS) of three European countries...
  70. ncbi Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists
    R Landewe
    University Hospital Maastricht, Department of Internal Medicine Rheumatology, Maastricht, Netherlands
    Ann Rheum Dis 63:530-4. 2004
    ..To determine the criteria considered important by Dutch rheumatologists in judging whether a patient with ankylosing spondylitis should start tumour necrosis factor (TNF) blocking therapy...
  71. ncbi Withdrawal from labour force due to work disability in patients with ankylosing spondylitis
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 60:1033-9. 2001
    ..To investigate withdrawal from the labour force because of inability to work owing to ankylosing spondylitis (AS) and to determine the characteristics of patients with no job because of work disability attributable to AS...
  72. ncbi High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis
    P Geusens
    Department of Rheumatology, University Hospital, University of Maastricht, The Netherlands
    J Rheumatol 28:1856-61. 2001
    ..To study the prevalence of deformities of vertebrae and intervertebral discs in patients with ankylosing spondylitis (AS) in relation to fixed hyperkyphosis of the spine...
  73. ncbi Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands
    Ann Rheum Dis 65:201-8. 2006
    ..To estimate the incremental cost-utility of etanercept and infliximab compared with usual care in active ankylosing spondylitis...
  74. ncbi Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review
    A Boonen
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    J Rheumatol 28:1056-62. 2001
    ..To evaluate work status and its determinants among patients with ankylosing spondylitis (AS)...
  75. ncbi Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts
    K Bruynesteyn
    Department of Rheumatology, University Hospital Maastricht, The Netherlands
    J Rheumatol 28:904-10. 2001
    ..The SDD is a conservative estimate of the MCID; our panel rated progression at or below this level as clinically significant...
  76. ncbi Clinical aspects, outcome assessment, and management of ankylosing spondylitis and postenteric reactive arthritis
    S van der Linden
    Department of Medicine, University of Maastricht, The Netherlands
    Curr Opin Rheumatol 12:263-8. 2000
    ..Recent advances in research on ankylosing spondylitis are reviewed here...
  77. ncbi Determinants of hyperkyphosis in patients with ankylosing spondylitis
    D Vosse
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 65:770-4. 2006
    ..To determine clinical and radiographic determinants of hyperkyphosis in patients with ankylosing spondylitis...
  78. ncbi Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission
    R Landewe
    Department of Internal Medicine Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands
    Ann Rheum Dis 65:637-41. 2006
    ..To compare 28 joint disease activity score (DAS28) remission with comprehensive joint count DAS remission in rheumatoid arthritis...
  79. ncbi Follow up studies in rheumatoid arthritis
    R Landewe
    University Hospital, Department of Internal Medicine Rheumatology, Maastricht, The Netherlands
    Ann Rheum Dis 61:479-81. 2002
  80. ncbi Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature
    K Visser
    Department of Rheumatology, Leiden University Medical Center, C1 R, P O Box 9600, 2300 RC Leiden, The Netherlands
    Clin Exp Rheumatol 27:1017-25. 2009
    ....
  81. ncbi EULAR/EFORT recommendations for the diagnosis and initial management of patients with acute or recent onset swelling of the knee
    R B M Landewé
    Maastricht University Medical Center, Department of Internal Medicine Rheumatology, PO Box 5800, 6202AZ Maastricht, The Netherlands
    Ann Rheum Dis 69:12-9. 2010
    ..The aim of the present work was to establish recommendations for the diagnosis and initial management of patients presenting with acute or recent onset swelling of the knee...
  82. ncbi Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change
    K Bruynesteyn
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 64:179-82. 2005
    ..This knowledge is important for calculation of the proportion of patients showing radiographic progression in clinical trials...
  83. ncbi Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature
    K Visser
    Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
    Ann Rheum Dis 68:1094-9. 2009
    ..To review systematically the available literature on the optimal dosage and route of administration of methotrexate in patients with rheumatoid arthritis (RA), as an evidence base for generating clinical practice recommendations...
  84. ncbi ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health
    A Boonen
    Maastricht University Medical Centre, Department of Internal Medicine, Division of Rheumatology, P Debyelaan 25, 6229 HX Maastricht, The Netherlands
    Ann Rheum Dis 69:102-7. 2010
    ....
  85. ncbi Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality?
    A van Tubergen
    University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 62:519-25. 2003
    ..To assess performance of radiologists and rheumatologists in detecting sacroiliitis..
  86. ncbi Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order
    A Wanders
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 63:1601-4. 2004
    ....
  87. ncbi Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel
    A van Tubergen
    Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands
    Ann Rheum Dis 62:215-21. 2003
    ..However, those patients who are considered as responders by applying the ASAS-IC are acknowledged as such by the expert panel as well as by patients' and doctors' judgments, and are therefore likely to be true responders...
  88. ncbi Psoriatic arthritis: performance of rheumatologists in daily practice
    S Gorter
    University Hospital Maastricht, Department of Internal Medicine, Division of Rheumatology, Maastricht, The Netherlands
    Ann Rheum Dis 61:219-24. 2002
    ..Rheumatologists focusing too much on the most prominent features (DIP joint arthritis) sometimes seem to forget "the hidden (skin) symptoms"...